Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 14Th February, 2024

Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 14th February, 2024 at 4:00 P.M. at S.F. Shop - 3/2/B Samruddhi Residency, Raspan Arcade, Cross Road, Nr. Satyam Complex, Nikol, Ahmedabad - 382 350 inter alia to consider and approve Unaudited Standalone Financial Results of the Company for the quarter and Nine Months ended on 31st December, 2023 along with Limited Review Report.
08-02-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th January, 2024

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 30th January, 2024 at the Registered Office of the Company which commenced at 2:00 P.M. and concluded at 6:30 P.M. inter-alia has, considered and approved as per attachment.
30-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Directorate

Announcement Under Regulation 30 (LODR) change in Directorate
19-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Director

Announcement under Regulation 30 (LODR) Resignation of Director
19-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

Announcement under Regulation 30 (LODR) Resignation of Managing Director
19-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018
19-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 30Th January, 2024

Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 ,inter alia, to consider and approve Proposal of raising of funds by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), subject to the receipt of necessary approvals.
17-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Management

Announcement Under Regulation 30 (LODR) Change in Management.
05-01-2024
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 5Th January, 2024

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today i.e. Friday, 5th January, 2024 at registered office of the company which commenced at 3:00 P.M. and concluded at 4:00 P.M. inter-alia has considered and approved: 1. Appointment of Mr. Tilva Manthan (DIN: 10453462) as Managing Director of the Company w.e.f 5th January, 2024 Subject to Approval of Shareholders in General Meeting. 2. Appointed Mr. Ladani Sanket (DIN: 10453446) as Additional Non-Executive Director of the Company w.e.f. 5th January, 2024 Subject to Approval of Shareholders in General Meeting.
05-01-2024
Next Page
Close

Let's Open Free Demat Account